Noveco Research Lab Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 18.88%
- Profit Growth 139.01%
- Ebitda 37.80%
- Net Worth 1.93%
- Total Assets 13.04%
About Noveco Research Lab
Noveco Research Lab Private Limited (NRLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 May 2016 (Eight years and nine months 3 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Sudarshan Joshi and Ajinkya Joshi serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999PN2016PTC164587
- Company No.
164587
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Noveco Research Lab Private Limited offer?
Noveco Research Lab Private Limited offers a wide range of products and services, including Surgical & Medical Consumables, Surgical Disposables.
Who are the key members and board of directors at Noveco Research Lab?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajinkya Joshi  | Director | 20-May-2016 | Current |
| Sudarshan Joshi | Director | 20-May-2016 | Current |
Financial Performance of Noveco Research Lab.
Noveco Research Lab Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.88% increase. The company also saw a substantial improvement in profitability, with a 139.01% increase in profit. The company's net worth moved up by a moderate rise of 1.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noveco Research Lab?
In 2020, Noveco Research Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Noveco Research Lab?
Unlock and access historical data on people associated with Noveco Research Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noveco Research Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noveco Research Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
